Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling.

Pyo, Min Kyung; Park, Hyung Sub; Ko, Jun Hwi; Lim, Do Su; Gwon, Hyeon Ji; Hassıbelnaby, Abdelaty Mostafa Abdelaty; Yağan, Ridvan; Song, Jin-Ho; Shin, Yong Kyoo; Jeong, Ji Hoon; Jung, Tae Woo

doi:10.1016/j.abb.2026.110820

Makale Tam Makale Uluslararası 2026

Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling.

Min Kyung Pyo, Hyung Sub Park, Jun Hwi Ko, Do Su Lim, Hyeon Ji Gwon, Abdelaty Mostafa Abdelaty Hassıbelnaby, Ridvan Yağan, Jin-Ho Song, Yong Kyoo Shin, Ji Hoon Jeong, Tae Woo Jung

Archives of Biochemistry and Biophysics Cilt 781 · 10.04.2026

DOI ile aç

Atıf için künye

Pyo, M. K., Park, H. S., Ko, J. H., Lim, D. S., Gwon, H. J., Hassıbelnaby, A. M. A., Yağan, R., Song, J., Shin, Y. K., Jeong, J. H., & Jung, T. W. (2026). Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling. Archives of Biochemistry and Biophysics, 781. https://doi.org/10.1016/j.abb.2026.110820

BibTeX

@article{pyo2026-209934,
  author = {Pyo, Min Kyung and Park, Hyung Sub and Ko, Jun Hwi and Lim, Do Su and Gwon, Hyeon Ji and Hassıbelnaby, Abdelaty Mostafa Abdelaty and Yağan, Ridvan and Song, Jin-Ho and Shin, Yong Kyoo and Jeong, Ji Hoon and Jung, Tae Woo},
  title = {Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling.},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  volume = {781},
  issn = {0003-9861},
  doi = {10.1016/j.abb.2026.110820},
  url = {https://akademik.atauni.edu.tr/yayinlar/209934-hepassocin-drives-egfr-dependent-endothelial-atherogenic-activation-via-nox1ros}
}